EPISODE · Oct 8, 2024 · 1 MIN
BOTOX Approval in China Redefines Jawline Aesthetics
from AI Automation Minute · host Dr. Teri Fisher
This episode discusses the recent approval of BOTOX® Cosmetic by Allergan Aesthetics in China for treating masseter muscle prominence (MMP), marking it as the first neurotoxin approved for this use in the country. Professor Sun Jiaming from Union Hospital shares insights into the rising demand for minimally invasive facial contouring among Asians. Clinical trials reveal a significant reduction in facial width and improvements in social interaction, attractiveness, and confidence for those receiving the treatment. Learn about the potential global impact and what this development means for individuals seeking a more refined jawline. Stay connected with Dr. Teri Fisher and explore the latest in AI and automation for healthcare: 🎥 Watch on YouTube for in-depth AI tutorials: YouTube.com/@DrTeriFisher📲 Follow on Instagram for automation tips: @DrTeriFisher💡 Discover AI tools for your practice: DrTeriFisher.com🎙 Listen to the long-form podcast: Anti-Aging Insights 👉 Subscribe to AI Automation Minute for your daily dose of AI-powered efficiency, and share with colleagues who want to work smarter, not harder! #AIAutomationMinute #DrTeriFisher #HealthcareAI
Embed this episode
What this episode covers
This episode discusses the recent approval of BOTOX® Cosmetic by Allergan Aesthetics in China for treating masseter muscle prominence (MMP), marking it as the first neurotoxin approved for this use in the country. Professor Sun Jiaming from Union Hospital shares insights into the rising demand for minimally invasive facial contouring among Asians. Clinical trials reveal a significant reduction in facial width and improvements in social interaction, attractiveness, and confidence for those rec...
NOW PLAYING
BOTOX Approval in China Redefines Jawline Aesthetics
No transcript for this episode yet
Similar Episodes
No similar episodes found.